# ieQip — AI for Regulatory Compliance

> AI for Regulatory Compliance (iPhone/iPad app by Wynngate Corporation.)

- Source: https://appshunter.io/ios/app/ieqip/id6792437864 (this page in markdown: same URL + `.md`)
- Developer: [Wynngate Corporation](https://appshunter.io/developer/6792437866)
- Category: Business, Reference
- Price: Free
- Age rating: 4+
- Requires: iOS 16.4 · 32 MB
- Languages: American English
- Released: 2026-08-18
- Data updated: 2026-09-26

## What is ieQip?

ieQip® (Intelligent Electronic Quality Inspection Platform) is an AI-powered quality and regulatory compliance platform developed to help life science organizations conduct efficient, consistent, and audit-ready inspections.

Built for pharmaceutical, biotechnology, medical device, dietary supplement, cosmetic, food, and related regulated industries, ieQip assists quality professionals in performing mock FDA inspections, internal audits, supplier assessments, and due diligence reviews while maintaining complete control of their confidential information.

Key Features

• AI-powered audit assistance for faster and more consistent inspections

• Generate mock FDA-483 observations and Establishment Inspection Reports (EIR)

• Conduct internal audits and third-party supplier assessments

• Identify compliance gaps and quality system weaknesses

• Standardize audit processes across multiple facilities

• Support CAPA and continuous quality improvement initiatives

• Secure enterprise deployment that allows organizations to retain full ownership and control of their audit data

• Designed for use by quality assurance, regulatory affairs, compliance teams, consultants, and internal auditors

Enterprise Solution

ieQip can be licensed directly to organizations, allowing companies to perform audits internally or through approved auditors while ensuring all inspection data remains under the organization's control. This reduces reliance on external systems and helps protect sensitive quality and regulatory information.

Who Uses ieQip?
- Pharmaceutical manufacturers
- Biotechnology companies
- Medical device manufacturers
- Dietary supplement manufacturers
- Food and cosmetic manufacturers
- Quality Assurance (QA) professionals
- Regulatory Affairs teams
- FDA compliance consultants
- Internal and third-party auditors

Whether you're preparing for an FDA inspection, strengthening your Quality Management System (QMS), or improving audit efficiency, ieQip provides intelligent tools that help your team identify risks earlier, streamline inspections, and maintain regulatory compliance.

## Is ieQip safe?

Not enough ratings yet to assess ieQip.

## Is ieQip legit?

ieQip has limited verification signals. The AppsHunter Legitimacy Score for ieQip is 58 out of 100 points across 7 verification signals from App Store and developer data.


## Version history (last 5 releases)

### 1.3.3 — 2026-09-05

This update includes:

Improved Market layout and alignment.
Inactive Markets are now hidden.
Subscription button now correctly shows the user's current plan.

### 1.3.0 — 2026-08-30

What’s New in Version 1.3.0:
Each market has a set price tag and the app saves each account's selected subscription plan and chosen markets and commodities.

### 1.2.2 — 2026-08-28

What’s New in Version 1.2.2:
Your selected subscription plan is now saved to your account and restored when you return. This release also includes reliability improvements.

### 1.2.1 — 2026-08-22

What’s New in Version 1.2.1
- Added CRL and USP regulatory market options.
- Simplified commodity selection with a focus on Drugs – Human.
- Introduced a new access-plan screen before starting a chat.
- Added secure response previews for free accounts.
- Improved selected market display across different screen sizes.
- Added clearer loading feedback when starting a chat.
- Improved app stability, navigation, and account experience.

### 1.0 — 2026-08-19

No release notes.

---

*Data collected daily from the US App Store and indexed by [AppsHunter](https://appshunter.io/). User reviews are verbatim App Store reviews. Ratings, prices and chart positions refresh continuously; this snapshot is from 2026-09-26.*